News

bg-news-7

Delay to Final Results, 2019 Annual Report and AGM

Following input from the Group’s auditors, Grant Thornton UK LLP, the Board is falling in line with the guidance from the FCA and the FRC and is delaying the publication of its final results for the year ended 31 December 2019 and audited annual report, previously scheduled for 26 March 2020, until such time as the FCA and FRC have provided clearer guidance.

The Group’s results for the year ended 31 December 2019 remain in line with the guidance given in the trading statement of 30 January 2020, based on the Company’s unaudited management accounts. The Board will provide further guidance in relation to the outlook for the year ending 31 December 2020 and beyond when the final results are published.

More details can be found here

 

Mello London 12th November 2019

Biome will be presenting and exhibiting at the popular “Mello London”, investor event on Tuesday 12th November.

Details can be found here.

Come along to hear about Biome and its exciting prospects.

Interim Results 2019

The Group has published its interim results covering the first half of 2019 and the information can be found here.

Trading Update H1 2019

The Group published its Trading Update on 22 July 2019 and reported total Group revenues for the first half of the year were £3.6m (H1 2018: £4.4m) with the Bioplastics division reporting a 53% increase in revenues over the same period in the prior year.

The full release can be read here.

Biome Technologies plc announces its Interim Results for the six months ended 30 June 2018.

Highlights

  • Group revenues in H1 2018 increased by 47% to £4.4m compared with the comparable period last year (H1 2017: £3.0m)
  • Biome generated an operating profit of £0.2m compared to an operating loss of £0.2m in the first half of 2017
  • Group cash position at 30 June 2018 of £2.3m (31 December 2017: £2.3m)

Paul Mines, Chief Executive Officer said:

“The Group had an outstanding first half to 2018 delivering an operating profit in the period. Opportunities within the Bioplastics division are increasing with substantial revenue potential in the medium term whilst the Stanelco RF division has delivered an exceptional start to the year. It is against this backdrop that Board remains confident in the Group’s outlook for 2018.”

The full interim results can be read here